{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T15:34:24Z","timestamp":1792683264944,"version":"4.5.0"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,9,16]],"date-time":"2022-09-16T00:00:00Z","timestamp":1663286400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,9,16]],"date-time":"2022-09-16T00:00:00Z","timestamp":1663286400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81700173"],"award-info":[{"award-number":["81700173"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2019M661938"],"award-info":[{"award-number":["2019M661938"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010242","name":"Jiangsu Planned Projects for Postdoctoral Research Funds","doi-asserted-by":"publisher","award":["2019K098"],"award-info":[{"award-number":["2019K098"]}],"id":[{"id":"10.13039\/501100010242","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sig Transduct Target Ther"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Interleukin 27 (IL-27), a heterodimeric cytokine composed of Epstein-Barr virus-induced 3 and p28, is a pleiotropic cytokine with both pro-and anti-inflammatory properties. However, the precise role of IL-27 in acute graft-<jats:italic>versus<\/jats:italic>-host disease is not yet fully understood. In this study, utilizing mice with IL-27 p28 deficiency in dendritic cells (DCs), we demonstrated that IL-27 p28 deficiency resulted in impaired Treg cell function and enhanced effector T cell responses, corresponding to aggravated aGVHD in mice. In addition, using single-cell RNA sequencing, we found that loss of IL-27 p28 impaired Treg cell generation and promoted IL-1R2<jats:sup>+<\/jats:sup>TIGIT<jats:sup>+<\/jats:sup> pathogenic CD4<jats:sup>+<\/jats:sup> T cells in the thymus at a steady state. Mechanistically, IL-27 p28 deficiency promoted STAT1 phosphorylation and Th1 cell responses, leading to the inhibition of Treg cell differentiation and function. Finally, patients with high levels of IL-27 p28 in serum showed a substantially decreased occurrence of grade II-IV aGVHD and more favorable overall survival than those with low levels of IL-27 p28. Thus, our results suggest a protective role of DC-derived IL-27 p28 in the pathogenesis of aGVHD through modulation of the Treg\/Teff cell balance during thymic development. IL-27 p28 may be a valuable marker for predicting aGVHD development after transplantation in humans.<\/jats:p>","DOI":"10.1038\/s41392-022-01147-z","type":"journal-article","created":{"date-parts":[[2022,9,16]],"date-time":"2022-09-16T00:02:40Z","timestamp":1663286560000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Dendritic cell-derived IL-27 p28 regulates T cell program in pathogenicity and alleviates acute graft-versus-host disease"],"prefix":"10.1038","volume":"7","author":[{"given":"Huanle","family":"Gong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoubao","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingyu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuangzhu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjing","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3894-0631","authenticated-orcid":false,"given":"Xiaojin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhinan","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongjian","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Di","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4652-469X","authenticated-orcid":false,"given":"Haiyan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4643-2098","authenticated-orcid":false,"given":"Yang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6312-3863","authenticated-orcid":false,"given":"Depei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,9,16]]},"reference":[{"key":"1147_CR1","doi-asserted-by":"publisher","first-page":"2091","DOI":"10.1056\/NEJMoa1004383","volume":"363","author":"TA Gooley","year":"2010","unstructured":"Gooley, T. A. et al. Reduced mortality after allogeneic hematopoietic-cell transplantation. N. Engl. J. Med. 363, 2091\u20132101 (2010).","journal-title":"N. Engl. J. Med."},{"key":"1147_CR2","doi-asserted-by":"publisher","first-page":"79","DOI":"10.3389\/fimmu.2017.00079","volume":"8","author":"S Ghimire","year":"2017","unstructured":"Ghimire, S. et al. Pathophysiology of GvHD and other HSCT-related major complications. Front. Immunol. 8, 79 (2017).","journal-title":"Front. Immunol."},{"key":"1147_CR3","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1182\/blood-2014-02-514745","volume":"124","author":"KA Markey","year":"2014","unstructured":"Markey, K. A., MacDonald, K. P. & Hill, G. R. The biology of graft-versus-host disease: experimental systems instructing clinical practice. Blood 124, 354\u2013362 (2014).","journal-title":"Blood"},{"key":"1147_CR4","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1038\/cmi.2016.37","volume":"15","author":"Y Cai","year":"2018","unstructured":"Cai, Y. et al. Adoptively transferred donor IL-17-producing CD4(+) T cells augment, but IL-17 alleviates, acute graft-versus-host disease. Cell Mol. Immunol. 15, 233\u2013245 (2018).","journal-title":"Cell Mol. Immunol."},{"key":"1147_CR5","first-page":"90","volume":"2","author":"S Kumar","year":"2017","unstructured":"Kumar, S., Mohammadpour, H. & Cao, X. Targeting cytokines in GVHD therapy. J. Immunol. Res. Ther. 2, 90\u201399 (2017).","journal-title":"J. Immunol. Res. Ther."},{"key":"1147_CR6","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1038\/leu.2014.310","volume":"29","author":"Y Liu","year":"2015","unstructured":"Liu, Y. et al. IL-35 mitigates murine acute graft-versus-host disease with retention of graft-versus-leukemia effects. Leukemia 29, 939\u2013946 (2015).","journal-title":"Leukemia"},{"key":"1147_CR7","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1146\/annurev-immunol-032414-112134","volume":"33","author":"H Yoshida","year":"2015","unstructured":"Yoshida, H. & Hunter, C. A. The immunobiology of interleukin-27. Annu. Rev. Immunol. 33, 417\u2013443 (2015).","journal-title":"Annu. Rev. Immunol."},{"key":"1147_CR8","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/j.immuni.2019.03.011","volume":"50","author":"ED Tait Wojno","year":"2019","unstructured":"Tait Wojno, E. D., Hunter, C. A. & Stumhofer, J. S. The immunobiology of the interleukin-12 family: room for discovery. Immunity 50, 851\u2013870 (2019).","journal-title":"Immunity"},{"key":"1147_CR9","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1074\/jbc.M111.294355","volume":"287","author":"J Diegelmann","year":"2012","unstructured":"Diegelmann, J., Olszak, T., Goke, B., Blumberg, R. S. & Brand, S. A novel role for interleukin-27 (IL-27) as mediator of intestinal epithelial barrier protection mediated via differential signal transducer and activator of transcription (STAT) protein signaling and induction of antibacterial and anti-inflammatory proteins. J. Biol. Chem. 287, 286\u2013298 (2012).","journal-title":"J. Biol. Chem."},{"key":"1147_CR10","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1182\/blood.2019003910","volume":"136","author":"H He","year":"2020","unstructured":"He, H. et al. Aging-induced IL27Ra signaling impairs hematopoietic stem cells. Blood 136, 183\u2013198 (2020).","journal-title":"Blood"},{"key":"1147_CR11","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1038\/s41577-018-0066-7","volume":"18","author":"SA Jones","year":"2018","unstructured":"Jones, S. A. & Jenkins, B. J. Recent insights into targeting the IL-6 cytokine family in inflammatory diseases and cancer. Nat. Rev. Immunol. 18, 773\u2013789 (2018).","journal-title":"Nat. Rev. Immunol."},{"key":"1147_CR12","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1016\/S1074-7613(02)00324-2","volume":"16","author":"S Pflanz","year":"2002","unstructured":"Pflanz, S. et al. IL-27, a heterodimeric cytokine composed of EBI3 and p28 protein, induces proliferation of naive CD4+ T cells. Immunity 16, 779\u2013790 (2002).","journal-title":"Immunity"},{"key":"1147_CR13","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.4049\/jimmunol.175.4.2191","volume":"175","author":"T Owaki","year":"2005","unstructured":"Owaki, T. et al. A role for IL-27 in early regulation of Th1 differentiation. J. Immunol. 175, 2191\u20132200 (2005).","journal-title":"J. Immunol."},{"key":"1147_CR14","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/S1074-7613(01)00206-0","volume":"15","author":"H Yoshida","year":"2001","unstructured":"Yoshida, H. et al. WSX-1 is required for the initiation of Th1 responses and resistance to L. major infection. Immunity 15, 569\u2013578 (2001).","journal-title":"Immunity"},{"key":"1147_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4049\/immunohorizons.1700054","volume":"2","author":"AM Kilgore","year":"2018","unstructured":"Kilgore, A. M. et al. IL-27p28 production by XCR1(+) dendritic cells and monocytes effectively predicts adjuvant-elicited CD8(+) T cell responses. Immunohorizons 2, 1\u201311 (2018).","journal-title":"Immunohorizons"},{"key":"1147_CR16","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1038\/ni1541","volume":"8","author":"A Awasthi","year":"2007","unstructured":"Awasthi, A. et al. A dominant function for interleukin 27 in generating interleukin 10-producing anti-inflammatory T cells. Nat. Immunol. 8, 1380\u20131389 (2007).","journal-title":"Nat. Immunol."},{"key":"1147_CR17","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/j.smim.2011.08.003","volume":"23","author":"C Pot","year":"2011","unstructured":"Pot, C., Apetoh, L., Awasthi, A. & Kuchroo, V. K. Induction of regulatory Tr1 cells and inhibition of T(H)17 cells by IL-27. Semin Immunol. 23, 438\u2013445 (2011).","journal-title":"Semin Immunol."},{"key":"1147_CR18","doi-asserted-by":"publisher","first-page":"108433","DOI":"10.1016\/j.celrep.2020.108433","volume":"33","author":"H Zhang","year":"2020","unstructured":"Zhang, H. et al. An IL-27-driven transcriptional network identifies regulators of IL-10 expression across T helper cell subsets. Cell Rep. 33, 108433 (2020).","journal-title":"Cell Rep."},{"key":"1147_CR19","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.1038\/ni1540","volume":"8","author":"DC Fitzgerald","year":"2007","unstructured":"Fitzgerald, D. C. et al. Suppression of autoimmune inflammation of the central nervous system by interleukin 10 secreted by interleukin 27-stimulated T cells. Nat. Immunol. 8, 1372\u20131379 (2007).","journal-title":"Nat. Immunol."},{"key":"1147_CR20","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1038\/ni1375","volume":"7","author":"M Batten","year":"2006","unstructured":"Batten, M. et al. Interleukin 27 limits autoimmune encephalomyelitis by suppressing the development of interleukin 17-producing T cells. Nat. Immunol. 7, 929\u2013936 (2006).","journal-title":"Nat. Immunol."},{"key":"1147_CR21","doi-asserted-by":"publisher","first-page":"10190","DOI":"10.1073\/pnas.1703100114","volume":"114","author":"J Do","year":"2017","unstructured":"Do, J. et al. Treg-specific IL-27Ralpha deletion uncovers a key role for IL-27 in Treg function to control autoimmunity. Proc. Natl Acad. Sci. USA 114, 10190\u201310195 (2017).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1147_CR22","doi-asserted-by":"publisher","first-page":"e2109548118","DOI":"10.1073\/pnas.2109548118","volume":"118","author":"JK Choi","year":"2021","unstructured":"Choi, J. K. et al. IL-27-producing B-1a cells suppress neuroinflammation and CNS autoimmune diseases. Proc. Natl Acad. Sci. USA 118, e2109548118 (2021).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1147_CR23","first-page":"672","volume":"44","author":"D Kimura","year":"2016","unstructured":"Kimura, D. et al. Interleukin-27-producing CD4(+) T cells regulate protective. Immun. Malar. Parasite Infect. Immun. 44, 672\u2013682 (2016).","journal-title":"Immun. Malar. Parasite Infect. Immun."},{"key":"1147_CR24","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1038\/s41586-021-04127-5","volume":"600","author":"Q Wang","year":"2021","unstructured":"Wang, Q. et al. IL-27 signalling promotes adipocyte thermogenesis and energy expenditure. Nature 600, 314\u2013318 (2021).","journal-title":"Nature"},{"key":"1147_CR25","doi-asserted-by":"publisher","first-page":"2068","DOI":"10.1182\/blood-2016-02-698241","volume":"128","author":"L Belle","year":"2016","unstructured":"Belle, L. et al. Blockade of interleukin-27 signaling reduces GVHD in mice by augmenting Treg reconstitution and stabilizing Foxp3 expression. Blood 128, 2068\u20132082 (2016).","journal-title":"Blood"},{"key":"1147_CR26","doi-asserted-by":"publisher","first-page":"2064","DOI":"10.1002\/eji.201444491","volume":"44","author":"RG Marillier","year":"2014","unstructured":"Marillier, R. G., Uyttenhove, C., Goriely, S., Marbaix, E., & Van Snick, J. IL-27p28 is essential for parent-to-F1 acute graft-versus-host disease. Eur. J. Immunol. 44, 2064\u20132073 (2014).","journal-title":"Eur. J. Immunol."},{"key":"1147_CR27","first-page":"151","volume":"3","author":"D Bastian","year":"2018","unstructured":"Bastian, D. et al. IL-27 receptor signaling on T cells augments GVHD severity through enhancing Th1 responses. J. Immunol. Res. Ther. 3, 151\u2013157 (2018).","journal-title":"J. Immunol. Res. Ther."},{"key":"1147_CR28","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1182\/blood-2018-07-863233","volume":"133","author":"A Daenthanasanmak","year":"2019","unstructured":"Daenthanasanmak, A. et al. Targeting Sirt-1 controls GVHD by inhibiting T-cell allo-response and promoting Treg stability in mice. Blood 133, 266\u2013279 (2019).","journal-title":"Blood"},{"key":"1147_CR29","doi-asserted-by":"publisher","first-page":"2651","DOI":"10.1182\/blood-2017-11-785865","volume":"131","author":"BR Blazar","year":"2018","unstructured":"Blazar, B. R., MacDonald, K. P. A. & Hill, G. R. Immune regulatory cell infusion for graft-versus-host disease prevention and therapy. Blood 131, 2651\u20132660 (2018).","journal-title":"Blood"},{"key":"1147_CR30","doi-asserted-by":"publisher","first-page":"e98745","DOI":"10.1172\/jci.insight.98745","volume":"3","author":"J Zhu","year":"2018","unstructured":"Zhu, J. et al. IL-27 gene therapy induces depletion of Tregs and enhances the efficacy of cancer immunotherapy. JCI Insight 3, e98745 (2018).","journal-title":"JCI Insight"},{"key":"1147_CR31","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1084\/jem.20100410","volume":"208","author":"JH Cox","year":"2011","unstructured":"Cox, J. H. et al. IL-27 promotes T cell-dependent colitis through multiple mechanisms. J. Exp. Med. 208, 115\u2013123 (2011).","journal-title":"J. Exp. Med."},{"key":"1147_CR32","doi-asserted-by":"publisher","first-page":"e123216","DOI":"10.1172\/jci.insight.123216","volume":"4","author":"QT Nguyen","year":"2019","unstructured":"Nguyen, Q. T. et al. IL-27 targets Foxp3+ Tregs to mediate antiinflammatory functions during experimental allergic airway inflammation. JCI Insight 4, e123216 (2019).","journal-title":"JCI Insight"},{"key":"1147_CR33","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/j.immuni.2012.06.014","volume":"37","author":"AO Hall","year":"2012","unstructured":"Hall, A. O. et al. The cytokines interleukin 27 and interferon-gamma promote distinct Treg cell populations required to limit infection-induced pathology. Immunity 37, 511\u2013523 (2012).","journal-title":"Immunity"},{"key":"1147_CR34","doi-asserted-by":"publisher","first-page":"181","DOI":"10.3389\/fimmu.2020.00181","volume":"11","author":"HT Le","year":"2020","unstructured":"Le, H. T. et al. Interleukin-27 enforces regulatory T cell functions to prevent graft-versus-host disease. Front. Immunol. 11, 181 (2020).","journal-title":"Front. Immunol."},{"key":"1147_CR35","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1002\/hep.26166","volume":"57","author":"S Zhang","year":"2013","unstructured":"Zhang, S. et al. High susceptibility to liver injury in IL-27 p28 conditional knockout mice involves intrinsic interferon-gamma dysregulation of CD4+ T cells. Hepatology 57, 1620\u20131631 (2013).","journal-title":"Hepatology"},{"key":"1147_CR36","first-page":"1","volume":"1","author":"J Heinrichs","year":"2016","unstructured":"Heinrichs, J. et al. Regulatory T-cell therapy for graft-versus-host disease. J. Immunol. Res. Ther. 1, 1\u201314 (2016).","journal-title":"J. Immunol. Res. Ther."},{"key":"1147_CR37","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1038\/ni1537","volume":"8","author":"JS Stumhofer","year":"2007","unstructured":"Stumhofer, J. S. et al. Interleukins 27 and 6 induce STAT3-mediated T cell production of interleukin 10. Nat. Immunol. 8, 1363\u20131371 (2007).","journal-title":"Nat. Immunol."},{"key":"1147_CR38","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.3389\/fimmu.2020.01837","volume":"11","author":"G Giardino","year":"2020","unstructured":"Giardino, G. et al. T-cell immunodeficiencies with congenital alterations of thymic development: genes implicated and differential immunological and clinical features. Front. Immunol. 11, 1837 (2020).","journal-title":"Front. Immunol."},{"key":"1147_CR39","doi-asserted-by":"publisher","DOI":"10.1038\/srep30448","volume":"6","author":"H Tang","year":"2016","unstructured":"Tang, H. et al. Thymic DCs derived IL-27 regulates the final maturation of CD4(+) SP thymocytes. Sci. Rep. 6, 30448 (2016).","journal-title":"Sci. Rep."},{"key":"1147_CR40","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.celrep.2017.09.016","volume":"21","author":"Z Hu","year":"2017","unstructured":"Hu, Z. et al. CCR7 modulates the generation of thymic regulatory T cells by altering the composition of the thymic dendritic cell compartment. Cell Rep. 21, 168\u2013180 (2017).","journal-title":"Cell Rep."},{"key":"1147_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-17046-2","volume":"11","author":"NG Nunez","year":"2020","unstructured":"Nunez, N. G. et al. Tumor invasion in draining lymph nodes is associated with Treg accumulation in breast cancer patients. Nat. Commun. 11, 3272 (2020).","journal-title":"Nat. Commun."},{"key":"1147_CR42","doi-asserted-by":"publisher","first-page":"eaaw0480","DOI":"10.1126\/sciadv.aaw0480","volume":"5","author":"TT Drashansky","year":"2019","unstructured":"Drashansky, T. T. et al. Bcl11b prevents fatal autoimmunity by promoting Treg cell program and constraining innate lineages in Treg cells. Sci. Adv. 5, eaaw0480 (2019).","journal-title":"Sci. Adv."},{"key":"1147_CR43","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1038\/ni.3646","volume":"18","author":"Y Kitagawa","year":"2017","unstructured":"Kitagawa, Y. et al. Guidance of regulatory T cell development by Satb1-dependent super-enhancer establishment. Nat. Immunol. 18, 173\u2013183 (2017).","journal-title":"Nat. Immunol."},{"key":"1147_CR44","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1038\/ni.2928","volume":"15","author":"M Miyazaki","year":"2014","unstructured":"Miyazaki, M. et al. Id2 and Id3 maintain the regulatory T cell pool to suppress inflammatory disease. Nat. Immunol. 15, 767\u2013776 (2014).","journal-title":"Nat. Immunol."},{"key":"1147_CR45","doi-asserted-by":"publisher","first-page":"3629","DOI":"10.1016\/j.celrep.2019.05.061","volume":"27","author":"BH Yang","year":"2019","unstructured":"Yang, B. H. et al. TCF1 and LEF1 control Treg competitive survival and Tfr development to prevent autoimmune diseases. Cell Rep. 27, 3629\u20133645.e3626 (2019).","journal-title":"Cell Rep."},{"key":"1147_CR46","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.immuni.2019.01.001","volume":"50","author":"RJ Miragaia","year":"2019","unstructured":"Miragaia, R. J. et al. Single-cell transcriptomics of regulatory T cells reveals trajectories of tissue adaptation. Immunity 50, 493\u2013504.e497 (2019).","journal-title":"Immunity"},{"key":"1147_CR47","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1038\/nature12199","volume":"498","author":"R Roychoudhuri","year":"2013","unstructured":"Roychoudhuri, R. et al. BACH2 represses effector programs to stabilize T(reg)-mediated immune homeostasis. Nature 498, 506\u2013510 (2013).","journal-title":"Nature"},{"key":"1147_CR48","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1016\/j.cell.2017.05.035","volume":"169","author":"C Zheng","year":"2017","unstructured":"Zheng, C. et al. Landscape of infiltrating T cells in liver cancer revealed by single-cell sequencing. Cell 169, 1342\u20131356.e1316 (2017).","journal-title":"Cell"},{"key":"1147_CR49","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1182\/blood.2019001696","volume":"135","author":"C Piper","year":"2020","unstructured":"Piper, C. et al. Pathogenic Bhlhe40+ GM-CSF+ CD4+ T cells promote indirect alloantigen presentation in the GI tract during GVHD. Blood 135, 568\u2013581 (2020).","journal-title":"Blood"},{"key":"1147_CR50","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1002\/eji.200838913","volume":"39","author":"JH Chang","year":"2009","unstructured":"Chang, J. H., Kim, Y. J., Han, S. H. & Kang, C. Y. IFN-gamma-STAT1 signal regulates the differentiation of inducible Treg: potential role for ROS-mediated apoptosis. Eur. J. Immunol. 39, 1241\u20131251 (2009).","journal-title":"Eur. J. Immunol."},{"key":"1147_CR51","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1016\/j.jhep.2015.12.020","volume":"64","author":"J Yan","year":"2016","unstructured":"Yan, J. et al. Interleukin-30 (IL27p28) alleviates experimental sepsis by modulating cytokine profile in NKT cells. J. Hepatol. 64, 1128\u20131136 (2016).","journal-title":"J. Hepatol."},{"key":"1147_CR52","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1136\/thoraxjnl-2014-205777","volume":"69","author":"J Cao","year":"2014","unstructured":"Cao, J. et al. IL-27 controls sepsis-induced impairment of lung antibacterial host defence. Thorax 69, 926\u2013937 (2014).","journal-title":"Thorax"},{"key":"1147_CR53","doi-asserted-by":"publisher","first-page":"e1008994","DOI":"10.1371\/journal.ppat.1008994","volume":"16","author":"M Montes de Oca","year":"2020","unstructured":"Montes de Oca, M. et al. IL-27 signalling regulates glycolysis in Th1 cells to limit immunopathology during infection. PLoS Pathog. 16, e1008994 (2020).","journal-title":"PLoS Pathog."},{"key":"1147_CR54","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1189\/jlb.1210699","volume":"89","author":"C Uyttenhove","year":"2011","unstructured":"Uyttenhove, C. et al. Amine-reactive OVA multimers for auto-vaccination against cytokines and other mediators: perspectives illustrated for GCP-2 in L. major infection. J. Leukoc. Biol. 89, 1001\u20131007 (2011).","journal-title":"J. Leukoc. Biol."},{"key":"1147_CR55","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1038\/s41590-021-00987-1","volume":"22","author":"A Osman","year":"2021","unstructured":"Osman, A. et al. TCF-1 controls Treg cell functions that regulate inflammation, CD8(+) T cell cytotoxicity and severity of colon cancer. Nat. Immunol. 22, 1152\u20131162 (2021).","journal-title":"Nat. Immunol."},{"key":"1147_CR56","doi-asserted-by":"publisher","first-page":"109096","DOI":"10.1016\/j.celrep.2021.109096","volume":"35","author":"H Zhang","year":"2021","unstructured":"Zhang, H. et al. Bach2 attenuates IL-2R signaling to control Treg homeostasis and Tfr development. Cell Rep. 35, 109096 (2021).","journal-title":"Cell Rep."},{"key":"1147_CR57","doi-asserted-by":"publisher","first-page":"1472","DOI":"10.1126\/science.7770771","volume":"268","author":"H Suzuki","year":"1995","unstructured":"Suzuki, H. et al. Deregulated T cell activation and autoimmunity in mice lacking interleukin-2 receptor beta. Science 268, 1472\u20131476 (1995).","journal-title":"Science"},{"key":"1147_CR58","doi-asserted-by":"publisher","first-page":"3891","DOI":"10.1073\/pnas.1200090109","volume":"109","author":"MS Fassett","year":"2012","unstructured":"Fassett, M. S., Jiang, W., D\u2019Alise, A. M., Mathis, D. & Benoist, C. Nuclear receptor Nr4a1 modulates both regulatory T-cell (Treg) differentiation and clonal deletion. Proc. Natl Acad. Sci. USA 109, 3891\u20133896 (2012).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1147_CR59","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1038\/nature11530","volume":"490","author":"P Li","year":"2012","unstructured":"Li, P. et al. BATF-JUN is critical for IRF4-mediated transcription in T cells. Nature 490, 543\u2013546 (2012).","journal-title":"Nature"},{"key":"1147_CR60","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1038\/ni.2834","volume":"15","author":"M Kurachi","year":"2014","unstructured":"Kurachi, M. et al. The transcription factor BATF operates as an essential differentiation checkpoint in early effector CD8+ T cells. Nat. Immunol. 15, 373\u2013383 (2014).","journal-title":"Nat. Immunol."},{"key":"1147_CR61","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1172\/JCI89242","volume":"128","author":"E Ullrich","year":"2018","unstructured":"Ullrich, E. et al. BATF-dependent IL-7RhiGM-CSF+ T cells control intestinal graft-versus-host disease. J. Clin. Invest. 128, 916\u2013930 (2018).","journal-title":"J. Clin. Invest."},{"key":"1147_CR62","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.clim.2017.08.015","volume":"187","author":"K Kielsen","year":"2018","unstructured":"Kielsen, K. et al. Soluble Interleukin-7 receptor levels and risk of acute graft-versus-host disease after allogeneic haematopoietic stem cell transplantation. Clin. Immunol. 187, 26\u201332 (2018).","journal-title":"Clin. Immunol."},{"key":"1147_CR63","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1038\/ni.1957","volume":"11","author":"JS Stumhofer","year":"2010","unstructured":"Stumhofer, J. S. et al. A role for IL-27p28 as an antagonist of gp130-mediated signaling. Nat. Immunol. 11, 1119\u20131126 (2010).","journal-title":"Nat. Immunol."},{"key":"1147_CR64","doi-asserted-by":"publisher","first-page":"4346","DOI":"10.1074\/jbc.M112.432955","volume":"288","author":"C Garbers","year":"2013","unstructured":"Garbers, C. et al. An interleukin-6 receptor-dependent molecular switch mediates signal transduction of the IL-27 cytokine subunit p28 (IL-30) via a gp130 protein receptor homodimer. J. Biol. Chem. 288, 4346\u20134354 (2013).","journal-title":"J. Biol. Chem."},{"key":"1147_CR65","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1073\/pnas.1816698116","volume":"116","author":"SI Muller","year":"2019","unstructured":"Muller, S. I. et al. A folding switch regulates interleukin 27 biogenesis and secretion of its alpha-subunit as a cytokine. Proc. Natl Acad. Sci. USA 116, 1585\u20131590 (2019).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1147_CR66","doi-asserted-by":"publisher","first-page":"2724","DOI":"10.3389\/fimmu.2018.02724","volume":"9","author":"H Gong","year":"2018","unstructured":"Gong, H. et al. IL-17C mitigates murine acute graft-vs.-host disease by promoting intestinal barrier functions and treg differentiation. Front. Immunol. 9, 2724 (2018).","journal-title":"Front. Immunol."},{"key":"1147_CR67","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.3389\/fimmu.2017.01605","volume":"8","author":"J Han","year":"2017","unstructured":"Han, J. et al. Inhibition of acute graft-versus-host disease with retention of graft-versus-tumor effects by dimethyl fumarate. Front. Immunol. 8, 1605 (2017).","journal-title":"Front. Immunol."},{"key":"1147_CR68","doi-asserted-by":"publisher","first-page":"904693","DOI":"10.3389\/fimmu.2022.904693","volume":"13","author":"X Tong","year":"2022","unstructured":"Tong, X. et al. Fucosylation promotes cytolytic function and accumulation of NK cells in B cell lymphoma. Front. Immunol. 13, 904693 (2022).","journal-title":"Front. Immunol."}],"container-title":["Signal Transduction and Targeted Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41392-022-01147-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41392-022-01147-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41392-022-01147-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,16]],"date-time":"2022-09-16T00:03:18Z","timestamp":1663286598000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41392-022-01147-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,16]]},"references-count":68,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["1147"],"URL":"https:\/\/doi.org\/10.1038\/s41392-022-01147-z","relation":{},"ISSN":["2059-3635"],"issn-type":[{"value":"2059-3635","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,16]]},"assertion":[{"value":"13 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"319"}}